Potential Antiangiogenic Treatment Eligibility of Patients With Squamous Non-Small–Cell Lung Cancer: EPISQUAMAB Study (GFPC 2015-01)
Cancer Management and Research - New Zealand
doi 10.2147/cmar.s219984
Full Text
Open PDFAbstract
Available in full text
Categories
Date
December 1, 2019
Authors
Publisher
Informa UK Limited